Humacyte (NASDAQ:HUMA) reported its Q1 earnings results on Friday, May 12, 2023 at 07:05 AM.
Here’s what investors need to know about the announcement.
Earnings
Humacyte missed estimated earnings by 71.43%, reporting an EPS of $-0.36 versus an estimate of $-0.21.
Revenue was down $233 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.19 which was followed by a 5.83% drop in the share price the next day.
Here’s a look at Humacyte’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.23 | -0.21 | -0.22 | -0.21 |
| EPS Actual | -0.04 | -0.25 | -0.19 | -0.19 |
| Revenue Estimate | 200K | 200K | 200K | 240K |
| Revenue Actual | 0 | 31K | 1.30M | 233K |
To track all earnings releases for Humacyte visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
